14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $26.63 $26.63 Wednesday, 20th Jul 2022 RTRX stock ended at $26.63. During the day the stock fluctuated 0% from a day low at $26.63 to a day high of $26.63.
90 days $26.63 $26.63
52 weeks $12.75 $31.65

Historical Retrophin prices

Date Open High Low Close Volume
Jul 20, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 19, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 18, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 15, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 14, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 13, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 12, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 11, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 08, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 07, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 06, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 05, 2022 $26.63 $26.63 $26.63 $26.63 0
Jul 01, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 30, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 29, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 28, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 27, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 24, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 23, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 22, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 21, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 17, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 16, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 15, 2022 $26.63 $26.63 $26.63 $26.63 0
Jun 14, 2022 $26.63 $26.63 $26.63 $26.63 0
Click to get the best stock tips daily for free!

About Retrophin

Retrophin Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious, catastrophic, or rare diseases. Its product line includes Cholbam, a cholic acid for the treatment of bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of peroxisomal disorders, such as Zellweger spectrum disorders in patients who exhibit manifestations of li... RTRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT